Prescription Required
This is a distinctive drug crafted to combat a unique form of cancer identified as multiple myeloma. This cancer majorly hits the bone marrow, turning a particular category of white blood cells, known as plasma cells, into malignant entities that multiply uncontrolled. The drug's therapeutic plan is targeted, striving to manage this formidable disease in adults who are 18 years or more.
This drug is deployed for cancer treatment purposes. It's applied in the management of multiple myeloma, which is a type of cancer that targets plasma cells.
The drug functions by detecting and binding to specific proteins present on cancer cells, thus aiding the immune system in their eradication.
Please ensure to consult with your medical practitioner before administering this drug.
If you miss a dose, inform your doctor immediately to reschedule.
Multiple myeloma is a type of cancer that affects the plasma cells, a critical component of the immune system found in the bone marrow. Plasma cells are responsible for producing antibodies, which play a crucial role in fighting infections and diseases. However, in multiple myeloma, these plasma cells become cancerous and multiply uncontrollably, crowding out healthy cells in the bone marrow.
Content Updated on
Sunday, 3 March, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA